A Novel Serum Based Biomarker Panel Has Complementary Ability to Preclude Presence of Early Lung Cancer for Low Dose CT (LDCT)

Oncotarget - United States
doi 10.18632/oncotarget.17477
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Low-Dose CT for Lung Cancer Screening

The Lancet Oncology
Oncology
2018English

P1.11-11 Comparing Lung Cancer Diagnosed by Low Dose CT (LDCT), Incidental Lung Nodule Program (ILNP), and Non-Program-Based Detection

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Low-Dose CT for Lung Cancer Screening – Authors' Reply

The Lancet Oncology
Oncology
2018English

Multimodal Lung Cancer Screening Using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG Biomarker Study

International Journal of Cancer
Cancer ResearchOncology
2017English

A National Survey of Lung Cancer Specialists’ Views on Low-Dose CT Screening for Lung Cancer in Korea

PLoS ONE
Multidisciplinary
2018English

Is Screening for Lung Cancer Using Low Dose Spiral CT Scanning Worthwhile?

Thorax
PulmonaryRespiratory Medicine
2005English

Metabolomics a Novel Biomarker in Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Complementary Longitudinal Serum Biomarkers to CA125 for Early Detection of Ovarian Cancer

Cancer Prevention Research
MedicineCancer ResearchOncology
2019English

P3.11-23 Adherence to Annual Low-Dose CT Lung Cancer Screening at a Large Academic Institution

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy